Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$2.16
-1.2%
$2.58
$1.98
$20.00
$16.72M-0.461.14 million shs30,357 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.71
-2.7%
$0.50
$0.19
$0.83
$17.69M1.1837,621 shs6,900 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$0.79
$3.36
$0.67
$5.70
$15.27M0.87363,697 shs658,153 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$1.91
-30.3%
$2.96
$1.61
$38.10
$3.40M0.51943,585 shs105,051 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
+3.32%+2.35%-15.01%-12.45%-85.94%
Biotricity, Inc. stock logo
BTCY
Biotricity
+10.13%+20.99%+45.94%+40.33%+98.29%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
+9.18%-0.37%-82.84%-81.89%-84.97%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-15.33%-9.02%+4.98%+231,999,900.00%+231,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$2.16
-1.2%
$2.58
$1.98
$20.00
$16.72M-0.461.14 million shs30,357 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.71
-2.7%
$0.50
$0.19
$0.83
$17.69M1.1837,621 shs6,900 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$0.79
$3.36
$0.67
$5.70
$15.27M0.87363,697 shs658,153 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$1.91
-30.3%
$2.96
$1.61
$38.10
$3.40M0.51943,585 shs105,051 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
+3.32%+2.35%-15.01%-12.45%-85.94%
Biotricity, Inc. stock logo
BTCY
Biotricity
+10.13%+20.99%+45.94%+40.33%+98.29%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
+9.18%-0.37%-82.84%-81.89%-84.97%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-15.33%-9.02%+4.98%+231,999,900.00%+231,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2.50
Moderate Buy$22.83955.14% Upside
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
2.00
HoldN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest XAGE, BTCY, ALUR, and NVNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2025
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
8/12/2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$32.11M0.52N/AN/A($30.08) per share-0.07
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M1.47N/AN/A($1.30) per share-0.55
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A$2.40 per shareN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$1.05M3.24N/AN/A($6.77) per share-0.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$7.20M-$12.53N/AN/AN/A-158.30%N/A-59.91%11/12/2025 (Estimated)
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$0.21N/AN/A-80.42%N/A-188.47%11/13/2025 (Estimated)
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$21.82M-$1.20N/AN/AN/AN/A-57.35%-53.49%10/29/2025 (Estimated)
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-$10.37MN/A0.00N/A-682.67%N/A-261.90%N/A

Latest XAGE, BTCY, ALUR, and NVNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2025Q2 2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$0.65-$0.57+$0.08-$1.28$6.20 million$3.38 million
8/14/2025Q2 2025
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A-$1.56N/A-$1.56N/A$0.50 million
7/31/2025Q2 2025
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$0.28-$0.33-$0.05-$0.33N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/A
2.02
1.70
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A
11.81
11.81
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A
0.47
0.30

Institutional Ownership

CompanyInstitutional Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
21.39%
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
34.71%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
24.22%

Insider Ownership

CompanyInsider Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
22.40%
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
16.00%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
5017.76 million6.02 millionOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
3019.25 million16.17 millionOptionable
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
141.78 million1.27 millionN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Allurion Technologies stock logo

Allurion Technologies NYSE:ALUR

$2.16 -0.03 (-1.19%)
As of 03:52 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.71 -0.02 (-2.70%)
As of 03:23 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

enVVeno Medical stock logo

enVVeno Medical NASDAQ:NVNO

$0.79 0.00 (0.00%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Longevity Health stock logo

Longevity Health NASDAQ:XAGE

$1.91 -0.83 (-30.29%)
As of 03:25 PM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.